Company / CapEx per Share
ROCKET PHARMACEUTICALS, INC. CapEx per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.06
FY2025
5-year range
$0.06 / $0.38
FY2021-FY2025
Trend
-40.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
CapEx per Share has declined for 4 consecutive years, from $0.38 in FY2021 to $0.06 in FY2025.
Based on SEC 10-K filings.
0.06 in FY2025 with a 5-year CAGR of +15.7%.
Declined from $0.10 to $0.06 over the past 2 years.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -44.3%
- 5-Year CAGR
- +15.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- ROCKET PHARMACEUTICALS, INC.'s capex per share has declined for 4 consecutive years.
- In FY2025, capex per share decreased 40.5% year-over-year.
- Peak capex per share was recorded in FY2021.
- Lowest capex per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.68 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.06 | -40.5% |
| FY2024 | $0.09 | -3.9% |
| FY2023 | $0.10 | -69.9% |
| FY2022 | $0.32 | -16.3% |
| FY2021 | $0.38 | +1337.9% |
| FY2020 | $0.03 | -17.6% |
| FY2019 | $0.03 | -34.7% |
| FY2018 | $0.05 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026